Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Achieve Life Sciences, Inc. (ACHV)

6.78 +0.06 (+0.89%)
At close: November 9 at 4:00:01 PM EST
6.71 -0.07 (-1.03%)
After hours: November 9 at 5:23:30 PM EST
Trade ACHV on Coinbase
Ticker Change
ACHV is trading under new symbol QUIT effective Nov. 10, 2026

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Erik Atkisson
Chief Legal Officer 521.02k -- 1972
Dr. Andrew D. Goldberg M.D.
CEO, President & Director -- -- 1982
Mr. Benjamin Halladay M.B.A.
Chief Financial Officer -- -- 1986
Mr. Jerry Wan
VP of Finance & Principal Accounting Officer -- -- 1982
Ms. Kaitlyn Tuson
Senior Vice President of Marketing & Communications -- -- --
Dr. Mark L. Rubinstein M.D.
Chief Medical Officer -- -- 1968
Mr. Mark Zappia
Senior Vice President of Commercial -- -- --
Mr. Ronald Dadino
Senior Vice President of Chemistry, Manufacturing & Controls and Supply Chain -- -- --
Ms. Gloria Cosgrove
Senior Vice President of Global Quality -- -- --
Ms. Nicole P. Jones
Vice President of Strategic Communications & Stakeholder Relations -- -- --

Achieve Life Sciences, Inc.

22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
604 210 2217 https://www.achievelifesciences.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
28

Description

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Corporate Governance

Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of November 1, 2026 is 5. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 5; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 10, 2026 at 1:30 PM UTC

Achieve Life Sciences, Inc. Earnings Date

Recent Events

October 1, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 8, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

June 2, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 29, 2026 at 12:00 AM UTC

PRE 14A: Proxy Statements

May 19, 2026 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

May 12, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 30, 2026 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

April 16, 2026 at 12:00 AM UTC

S-8: Offering Registrations

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: